ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¼òÎÄÑ£¬£¬ÌÆÐ¡Ó꣩¿ËÈÕ£¬£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½Ôº½áÖ±³¦Íâ¿Æ¡¢Î¸³¦Ñо¿ËùÍô½¨Æ½¡¢ÂæÑÜС¢Óí»ã´¨ÍŶÓÏòµ¼Íê³ÉÁËÒ»Ïî¹ú¼Ê¶àÖÐÐÄÑо¿¡£Í¨¹ýÑо¿±í¹Û»ùÒò×éÖÐÏÊΪÈËÖªµÄ¡°°µÎïÖÊ¡±¡ª¡ªCpGØÑ·¦ÇøµÄ¼×»ù»¯£¬£¬£¬¿ª·¢ÁËÒ»ÏîÄÜ׼ȷʶ±ðÔçÆÚ½áÖ±³¦°©¸´·¢·çÏÕµÄÐÂÐÍ·Ö×Ó±ê¼ÇÎï×éºÏMePEC¡£ÂÛÎĽÒÏþÓÚÖ×Áöѧ¹ú¼ÊȨÍþÆÚ¿¯¡ª¡ªJournal of the National Cancer Institute£¨ÃÀ¹ú¹ú¼Ò°©Ö¢Ñо¿ËùÔÓÖ¾, IF=11.8£©£¬£¬£¬ÆÚ¿¯ÅäÒÔͬÆÚÉçÂÛÎÄÕ¡£

ͼ1 Ö×Áö±í¹Û»ùÒò×éÖеġ°°µÎïÖÊ¡±
ÂÛÎÄÎÊÌâΪ¡°DNA Methylation Profile in CpG-depleted Regions Uncovers a High-risk Subtype of Early-stage Colorectal Cancer¡±£¨»ùÓÚCpGØÑ·¦Çø¼×»ù»¯Í¼Æ×µÄÔçÆÚ½á³¦Ö±³¦°©¸´·¢·çÏÕ·ÖÐÍ£©¡£Á¥ÊôµÚÁùÒ½ÔºÍô½¨Æ½½ÌÊÚ¡¢ÃÀ¹úFred Hutchinson°©Ö¢Ñо¿ÖÐÐĵÄWilliam M. Grady½ÌÊÚÒÔ¼°Á¥ÊôµÚÁùÒ½ÔºÂæÑÜÐÂÖ÷ÈÎҽʦΪÂÛÎĵÄͨѶ×÷ÕߺÍÅäºÏ¸ß¼¶×÷Õߣ¬£¬£¬Á¥ÊôµÚÁùÒ½ÔºÓí»ã´¨¸±Ñо¿Ô±ÎªÂÛÎĵĵÚÒ»×÷Õß¡£
½áÖ±³¦°©ÊÇÌìÏÂÉÏ×î³£¼ûµÄ¶ñÐÔÖ×ÁöÖ®Ò»¡£ÆäÖÐÔ¼40%µÄ»¼ÕßÌåÏÖΪÔçÆÚ½áÖ±³¦°©£¨IÆÚ»òIIÆÚ£©£¬£¬£¬Õⲿ·Ö»¼Õß´ó¶à¿Éͨ¹ý¸ùÖÎÐÔÊÖÊõ»ñµÃÁÙ´²ÖÎÓú£¬£¬£¬µ«ÈÔÓÐ20-25%µÄ»¼ÕßÒòÖ×Áö¸´·¢¶øéæÃü£¬£¬£¬Ê¶±ðÕⲿ·Ö»¼Õß²¢¸øÓèÊÖÊõºóµÄ¸¨Öú»¯ÁÆÖÁ¹ØÖ÷Òª¡£ÏÖÔÚ£¬£¬£¬Õⲿ·Ö»¼ÕßµÄʶ±ðÖ÷ÒªÒÀÀµÓÚÁÙ´²-²¡Àí·çÏÕÒòËØ£¬£¬£¬°üÀ¨³¦µÀ¹£×è¡¢Ö×Áö´©¿×¡¢ÁÜͶºÏÇåɨÊýÄ¿¡¢Ö×Áö·Ö»¯¡¢Âö¹Ü°©Ë¨¡¢Éñ¾Êø½þÈó¡¢Î¢ÎÀÐÇÎȹÌ״̬µÈ¡£
MePEC·ÖÐÍ¿ÉÒÔ׼ȷµØÆÀ¹ÀÔçÆÚ½áÖ±³¦°©µÄ¸´·¢·çÏÕ£¬£¬£¬·çÏձȿ¿½ü3£¬£¬£¬¼´MePEC·ÖÐ͸ߵij¦°©»¼Õ߸´·¢·çÏÕÉý¸ß3±¶¡£Ñо¿·¢Ã÷£¬£¬£¬MePEC-H»¼Õß¾ßÓиü¸ßµÄ¸´·¢·çÏÕ£¬£¬£¬ÕâÒ»Ñо¿Ð§¹û½«¸ÄÉÆÏÖÔÚµÄÁÙ´²-²¡Àí·çÏÕ·Ö²ãϵͳ£¬£¬£¬²¢ÎªÔçÆÚ½áÖ±³¦°©µÄÖÎÁƾöÒéÌṩ×ÊÖú¡£

ͼ2 MePECÆÀ¹ÀÔçÆÚ½áÖ±³¦°©µÄ¸´·¢ºÍéæÃü·çÏÕ
ÃÀ¹ú¼ÍÄî˹¡¿ÌØÁÕ°©Ö¢ÖÐÐĵÄPaul Romesser½ÌÊÚΪÂÛÎÄ׫дÁËͬÆÚÉçÂÛ£º£º£ºÕâÏîÑо¿¿ª·¢µÄMePEC·ÖÐÍ£¬£¬£¬¿ÉÒÔÔÚÁÙ´²Êµ¼ùÖÐÒÔ¾ßÓб¾Ç®Ð§ÒæµÄ·½Ê½ÆÕ±éÓ¦Ó㻣»MePEC¿É¶ÔÔçÆÚ½áÖ±³¦°©µÄ¸´·¢·çÏÕ¾ÙÐзÖÀ࣬£¬£¬ÏÖÔÚÒѾÔÚ²î±ðÈËȺ×é³ÉµÄ¹ú¼Ê¶àÖÐÐÄÐÐÁÐÖоÙÐÐÁËÑéÖ¤£¬£¬£¬ÖµµÃÔÞËÌ¡£Ñо¿µÄÁíÒ»ÏîТ˳ÊÇ£¬£¬£¬¿ª·¢²¢Ó¦ÓÃÁËÐÂÐͼ׻ù»¯¼ì²âÒªÁ죬£¬£¬Õ½Ê¤ÁËÒÔǰ¼×»ù»¯Ñо¿µÄÊÖÒÕ¾ÖÏÞÐÔ£¬£¬£¬´ó´óÔö½øÁËδÀ´Ö×Áö¼×»ù»¯±ê¼ÇÎïµÄÑо¿¡£
Ñо¿ÍŶÓÔÚ¹ú¼Ò973ÍýÏëÏîÄ¿ºÍÁ¥ÊôµÚÁùÒ½ÔºÈ˲ÅÏîÄ¿µÄ×ÊÖúÏ£¬£¬£¬¼á³ÖÃæÏòÈËÃñÉúÃü¿µ½¡¡¢ÃæÏòÌìÏ¿Ƽ¼Ç°ÑØ£¬£¬£¬Ò»Ö±Ïò½áÖ±³¦°©¾«×¼ÕïÁƺͱí¹Û»ùÒò×é¡°ÎÞÈËÇø¡±½ø¾ü¡£´Ó²¶»ñ±í¹Û»ùÒò×éÖС°°µÎïÖÊ¡±µÄÖ×Áö±ê¼ÇÎï¼ÛÖµ×îÏÈ£¬£¬£¬µ½×ÔÖ÷Ñз¢QASMÊÖÒÕ½â¾ö¼ì²âÄÑÌ⣬£¬£¬ÔÙµ½º£ÄÚÍâ¶à¸öÖøÃûÒ½ÁÆÖÐÐĵÄÓ¦ÓúÍÑéÖ¤£¬£¬£¬×ܹ²Àúʱ7Äê¡£

ͼ3 MePECÑз¢Ê±¼äÏß
ÖµµÃÒ»ÌáµÄÊÇ£¬£¬£¬ÕâÏîÐÂÐͱê¼ÇÎïµÄ¼ì²â½ÓÄɵÄÊÇÍŶÓ×ÔÖ÷Ñз¢µÄµÚÈý´ú¼×»ù»¯ÌØÒìÐÔPCRÊÖÒÕ¡ª¡ªQASM£¨Clinical Chemistry 2019, IF=12.1£©£¬£¬£¬¿ÉÒÔÔÚµ¥¼î»ù·Ö±æÂÊÏÂʵÏÖCpGλµãµÄ¼×»ù»¯¼ì²â£¬£¬£¬½â¾öÁË»ùÒò×éCpGØÑ·¦Çø¼×»ù»¯PCR¶¨Á¿µÄÄÑÌ⣬£¬£¬ÈëѡĥÁ·Ò½Ñ§¹ú¼Ê¶¥¼¶ÆÚ¿¯Clinical ChemistryÄê¶È×î¸ßÔĶÁÁ¿ÂÛÎÄ£¨2019Ä꣩ºÍÌìϸ߼ÛֵרÀûÏîÄ¿£¨2021Ä꣩¡£

ͼ4 ¸ß·Ö±æÂʼì²â»ùÒò×é¼×»ù»¯Ë®Æ½µÄÐÂÊÖÒÕÑз¢
Ñо¿ÍŶӻ®·Ö¹¹½¨ÁËÖ×ÁöºÍ¸´·¢ÌØÒìµÄDNA¼×»ù»¯Í¼Æ×£¬£¬£¬·¢Ã÷ÔÚÖ×Áöɸ²éºÍÕï¶ÏÖÐÌåÏÖÓÅÒìµÄ¼×»ù»¯ÌØÕ÷ÓëÔÚÖ×Áö¸´·¢Ô¤²âÖÐÌåÏÖÓÅÒìµÄ¼×»ù»¯ÌØÕ÷±£´æÖØ´ó²î±ð£¬£¬£¬CpGØÑ·¦ÇøÓòµÄ¼×»ù»¯ÌØÕ÷±ÈCpG¸»¼¯ÇøÓòÄܸüÓÐÓõØÔ¤²â¸´·¢£¬£¬£¬ÕâЩ·¢Ã÷¸Ä±äÁ˼ÈÍù¹ØÓÚÖ×Áö±ê¼ÇÎïµÄÈÏÖª¡£

ͼ5 Óë½áÖ±³¦°©¸´·¢Ïà¹ØµÄCpGØÑ·¦ÇøÓòµÄDNA¼×»ù»¯Æ×
»ùÓÚÕâЩ·¢Ã÷£¬£¬£¬ÍŶӽÓÄÉ»úеѧϰµÄÒªÁì¹¹½¨ÁËMePEC·ÖÐÍ£¬£¬£¬È»ºóʹÓÃQASMÊÖÒÕʵÏÖ¿ìËÙ¡¢ÎÞаºÍ¾¼ÃµÄ¼ì²â£¬£¬£¬×îºóÓÉÖйú£¨ngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½Ôº¡¢ngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½Ôº¡¢ngµç×ÓÓÎÏ·Ö×Áö·ÀÖÎÖÐÐÄ¡¢ÄÏ·½Ò½Ôº¡¢ÖйúÈËÃñ½â·Å¾üˮʦ¾üÒ½´óѧµÈ£©¡¢ÃÀ¹ú£¨»ªÊ¢¶Ù´óѧºÍ÷°ÂҽѧÖÐÐĵȣ©¡¢¼ÓÄô󣨶àÂ×¶à´óѧµÈ£©ºÍ°Ä´óÀûÑÇ£¨Ä«¶û±¾´óѧ£©µÈ¶à¹úѧÕßÐÁ¦Íê³ÉÓ¦ÓúÍÑéÖ¤£¬£¬£¬ÔÚÔçÆÚ½áÖ±³¦°©»¼ÕßÖÐʵÏָ߸´·¢·çÏÕµÄ׼ȷԤ²â¡£

ͼ6 MePEC·ÖÐ͵Ŀª·¢ÓëÓ¦ÓÃ
MePEC·ÖÐÍ¿ÉÓÃÓÚÇø·Ö²î±ð¸´·¢·çÏÕµÄÔçÆÚ½áÖ±³¦°©»¼Õߣ¬£¬£¬Ê¶±ð³ö¿ÉÊÜÒæÓÚ¸¨ÖúÖÎÁƺÍÇ×½üËæ·ÃµÄ»¼Õߣ¬£¬£¬ÎªÔçÆÚ½áÖ±³¦°©»¼ÕßµÄÕïÁƾöÒéÌṩÓмÛÖµµÄÐÅÏ¢£¬£¬£¬Í¬Ê±»¹ÔÚÏÖÔÚ½áÖ±³¦°©·Ö×Ó·ÖÐ͵Ļù´¡ÉϾÙÐÐÁËÔ½·¢¾«×¼µÄϸ·Ö¡£
ÂÛÎÄÁ´½Ó£º£º£ºhttps://academic.oup.com/jnci/advance-article-abstract/doi/10.1093/jnci/djac183/6726193?redirectedFrom=fulltext